[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2018/154520,2018,A1
[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/44206,2020,A1
137114-68-2
703-67-3
93742-85-9
2840-44-0
84315-25-3
110931-79-8
88770-19-8 | Methyl 2-bromothiophene-4-carboxylate | AA00GZL6 | MFCD13386488
903094-72-4 | 1-(1-tert-Butoxycarbonyl-pyrrolidin-3-yl)-piperidine-3-carboxylic acid | AA00H05Y | MFCD06657439
90643-45-1 | Benzenesulfonamide, 2,4,5-trimethyl- (7CI,9CI) | AA00H0O5 | MFCD00456427
921602-83-7 | 2,2-Difluorocyclohexanamine hydrochloride | AA00H0XF | MFCD11878024
899823-76-8 | (5-BICYCLO[2.2.1]HEPT-2-ENYL)DIMETHYLETHOXYSILANE | AA00H1BM
902836-58-2 | 4-(2-Methylphenyl)oxane-4-carbaldehyde | AA00H1OJ | MFCD08061009
886361-37-1 | 1-[2-Amino-5-(3-methylpiperidino)phenyl]-1-ethanone | AA00H1WH | MFCD08276954
916421-44-8 | 4-(1-(tert-Butoxycarbonyl)piperidin-3-yl)benzoic acid | AA00H1ZX | MFCD02178899
883731-63-3 | (3,3-Difluorocyclopentyl)methanol | AA00H2M1 | MFCD22199415
861444-92-0 | 2-Methyl-2-(tetrahydro-2H-pyran-4-yl)propanoic acid | AA00H2YN | MFCD18374731